Navamedic ASA: Broad launch for Eroxon® in Sweden today Published: 06.05.2024 Navamedic ASA: Annual Report 2023 Published: 30.04.2024 Navamedic Q1 2024: Successful product launch and steady operational progress Published: 30.04.2024 Navamedic ASA: Invitation to 2024 1st quarter presentation Published: 23.04.2024 Navamedic welcomes new shareholders Published: 13.03.2024 Navamedic Q4 and full year 2023: A year marked by new records and transformative growth initiatives Published: 15.02.2024 FirstPrevious12345NextLast
Navamedic Q4 and full year 2023: A year marked by new records and transformative growth initiatives Published: 15.02.2024